Can topical tretinoin cause melasma or worsen existing melasma?

Tretinoin Does Not Cause Melasma

Topical tretinoin does not cause melasma; rather, it is an established treatment for melasma and may cause temporary hyperpigmentation as a side effect, which is distinct from melasma itself. The concern about tretinoin "causing" melasma appears to be a misunderstanding of its known adverse effect profile.

Evidence from FDA Drug Labeling

According to FDA prescribing information for tretinoin, the documented adverse effects include "hyper-/hypopigmentation" 1. This refers to temporary pigmentary changes that can occur during treatment, not the development of true melasma. The FDA label specifically states: "Temporary hyper- or hypopigmentation has been reported with repeated application of tretinoin" and notes that "all adverse effects of tretinoin have been reversible upon discontinuance of therapy" 2.

Tretinoin as a Treatment for Melasma

The evidence actually demonstrates that tretinoin is an effective treatment component for melasma, not a cause:

• Triple-combination therapy (hydroquinone 4% + tretinoin 0.05% + fluocinolone acetonide 0.01%) is significantly more effective than hydroquinone alone (RR 1.58,95% CI 1.26-1.97) for treating melasma 3

• Multiple studies confirm tretinoin's efficacy in melasma treatment, with evidence supporting its use both as monotherapy (grade B evidence) and in combination formulations 4

• Recent studies in Middle Eastern and Chinese populations demonstrate that triple-combination creams containing tretinoin significantly reduce melasma severity (mMASI scores) with good tolerability 5, 6

Understanding the Pigmentation Side Effect

The key distinction is between:

1. Melasma: A chronic acquired disorder of hyperpigmentation with specific patterns (epidermal, dermal, or mixed types)
2. Tretinoin-induced hyperpigmentation: A temporary, reversible side effect that resolves with discontinuation

Important Clinical Considerations:

• Sun exposure is the critical factor: The FDA label emphasizes that "exposure to sunlight, including sunlamps, should be minimized during the use of tretinoin" and warns of "heightened susceptibility to sunlight" 2. This photosensitivity can lead to increased pigmentation if sun protection is inadequate.

• Irritation-related pigmentation: Tretinoin commonly causes erythema, peeling, and skin irritation 1. In darker-skinned individuals (Fitzpatrick types IV-VI), this irritation can trigger post-inflammatory hyperpigmentation, which may be mistaken for melasma.

Clinical Pitfalls to Avoid

The most common mistake is inadequate sun protection during tretinoin therapy. Patients must:

• Use broad-spectrum sunscreen daily
• Avoid sun exposure when possible
• Minimize treatment frequency if excessive irritation occurs

For patients with existing melasma or darker skin types, the 2016 AAD guidelines note that azelaic acid may be preferable initially "because of the lightening effect of the product on dyspigmentation" 1.

Practical Management

If hyperpigmentation develops during tretinoin use:

1. Assess sun protection compliance - This is usually the culprit
2. Reduce application frequency to minimize irritation
3. Consider formulation changes - Newer microsphere formulations or adapalene may be better tolerated 7
4. Distinguish from true melasma - Tretinoin-induced changes should improve with discontinuation, while melasma is chronic and relapsing

Bottom line: Tretinoin is a cornerstone treatment for melasma, not a cause. Any pigmentary changes that occur are typically due to inadequate photoprotection or irritation-induced post-inflammatory hyperpigmentation, both of which are preventable and reversible.